chemical hazard Recalls

1,003 recalls tagged with “chemical hazard”.

Health & Personal Care
HIGH
FDA DRUG

Zydus Chlorpromazine Hydrochloride 200 mg Recall Expands Nationwide Over CGMP Deviations

The FDA confirms a nationwide recall of Zydus Lifesciences Chlorpromazine Hydrochloride tablets 200 mg (NDC 70710-1133-1) distributed by Zydus Pharmaceuticals USA. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake. Consumers and healthcare providers should stop using the product immediately and contact the distributor for guidance.

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Tablets Recalled for N-Nitroso Desmethyl Chlorpromazine Beyond FDA

Chlorpromazine Hydrochloride Tablets, 200 mg, 100-count bottle, manufactured by Zydus Lifesciences Ltd. and distributed by Northstar Rx LLC, are under recall nationwide in the United States. The CGMP deviation involves elevated levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop use and contact their healthcare provider.

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets 25 mg 100-count Recall 2025

Zydus Lifesciences and Northstar Rx LLC recall Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottles nationwide in the United States. The recall cites CGMP deviations and the presence of N-nitroso desmethyl chlorpromazine above acceptable intake limits. Consumers should stop using the product and contact the manufacturer or a healthcare provider for guidance.

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets Recall 100-Count Bottles (2025)

Zydus Lifesciences Ltd. recalled chlorpromazine hydrochloride tablets nationwide in the United States after tests found N-Nitroso Desmethyl Chlorpromazine above the acceptable intake limit. The issue involves CGMP deviations in manufacturing at the India facility and distribution by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. Healthcare providers and patients should stop using the product, 0

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Sun Pharmaceutical Radiopharmaceutical Kit Recall: 1,870 Kits Recalled for OOS Dissolution Issue

Sun Pharmaceutical Industries recalled 1,870 kits nationwide after an out-of-specification dissolution test for sulphate in Sodium Tartrate Dihydrate used to produce Mertiatide. The recall affects Rx-only kits distributed across the U.S. Healthcare providers and patients should stop using the product immediately and follow guidance from Sun Pharmaceutical. Contact information is provided by the UQ

Sun Pharmaceutical Industries
Failed Dissolution
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride 100 mg Recall 2025

Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc. recall Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottles distributed nationwide in the United States. The recall stems from CGMP deviations that allowed N-Nitroso Desmethyl Chlorpromazine to exceed the acceptable intake limit. Health care providers and patients should stop using the product and contact the manufacturer

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride 25 mg 100-count Tablets Recalled Nationwide (2025)

Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride tablets, 25 mg, 100-count bottles distributed nationwide by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake limit. Stop using the product and contact your healthcare provider or Zydus Pharmaceuticals (USA) Inc. for

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets Recalled for N-nitroso Contamination

Zydus Lifesciences recalled an undisclosed number of Chlorpromazine Hydrochloride Tablets due to N-nitroso desmethyl chlorpromazine contamination. Laboratory tests detected this chemical above the acceptable intake limit posing serious health risks. Consumers must stop using the tablets immediately and consult with healthcare providers for guidance.

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride 100 mg Recall 2025

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets, 100 mg, 100-count bottles distributed nationwide in the USA for Northstar Rx LLC, Memphis, TN 38141, are recalled. The recall cites CGMP deviations with the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake. Healthcare providers and patients should stop using the product immediately and contact the manufacturer or a医

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Viorele Desogestrel/Ethinyl Estradiol Recall 2025 for Impurities

Viorele birth-control pills are recalled in the United States for failed impurity and degradation specifications. Glenmark Pharmaceuticals Inc. is distributing the issue nationwide, affecting 26,928 packs. Patients should stop using the product and contact a clinician for guidance.

Viorele
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DEVICE

Beckman Coulter Phosphorus Reagent Recall: 2,146 Units for Calibration Failures

Beckman Coulter recalled 2,146 units of the SYNCHRON Systems Phosphorus (PHOSm) Reagent due to calibration failures that may delay patient results. Specific reagent lots may not function properly before their expiration date. Healthcare providers and patients must stop using these reagents immediately and follow manufacturer instructions.

Beckman Coulter
Specific SYNCHRON
Read more
Health & Personal Care
HIGH
FDA DEVICE

Inpeco Recall: 8 FlexLab FLX Potassium Test System Units Over Unverified HIL Function (2025)

Inpeco recalled eight FlexLab FLX System Potassium Test System units sold in California and New York. The recall targets the Sample Integrity Module HIL function, which detects hemolysis, icterus and lipemia. The FDA has not evaluated this function for safety or effectiveness, risking erroneous results or delays. Labs should stop using the device immediately.

Inpeco
The FlexLab
Read more
Food & Beverages
HIGH
FDA FOOD

New Spirit Naturals Ultra Whey Protein Powder Recalled for Undeclared Milk Allergen

New Spirit Naturals recalled 37 units of Ultra Whey Protein Powder sold directly through its online store after undeclared milk allergen was detected. The recall is currently active with a high-hazard designation. Consumers who have purchased the product should not consume it and should contact the company for refunds or replacements.

New Spirit Naturals
undeclared allergen
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Sulfamethoxazole and Trimethoprim 800 mg/160 mg 100-Tablets Recall 2025

Major Pharmaceuticals recalls sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets sold nationwide. A specific lot of packaging coil used in production was found to contain a microorganism in the packaging area, though no microorganism was detected on the tablets. Consumers should stop using the product and follow guidance from Major Pharmaceuticals or their healthcare provider.

Sulfamethoxazole and Trimethoprim
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

High-Risk Antibiotic Recall: Sulfamethoxazole and Trimethoprim 800/160 mg Double Strength Packets Re

A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.

SULFAMETHOXAZOLE AND TRIMETHOPRIM
Presence of
Read more
Health & Personal Care
HIGH
FDA DEVICE

Canon Medical System SPOT Fluoro Digital Radiography System Recall Affects 8 Units in US (2025)

Canon Medical System, USA recalls 8 SPOT Fluoro digital radiography systems in the United States after a software defect could expose patients to unintended X-ray exposure. The issue occurs when the acquisition program changes and the default ROI causes the collimator and static image to partially cover the collimated area. Stop using the affected devices and follow manufacturer instructions for a

Canon Medical System
It has
Read more
Health & Personal Care
HIGH
FDA DRUG

Fagron Compounding Services Bevacizumab Syringe Recall Affects 109,320 Units Nationwide

Fagron Compounding Services recalls 109,320 sterile single-dose bevacizumab syringes nationwide due to lack of assurance of sterility. Healthcare providers and patients should stop using the product immediately. Contact Fagron Compounding Services or a healthcare provider for guidance. The recall was issued on 2025-08-29 and remains active as of 2025-09-24.

Fagron Compounding Services
Lack of
Read more
Previous
12345...51
Next

Tag Statistics

Total Recalls
1,003

Related Tags

choking hazardelectrical hazardimmediate actionreturn for refundnhtsa regulatedfda regulatedpoisoning riskadult producttoddler productkitchenbathroomstop use immediately